Among them, only nine have been approved as “tumor associated antigens” by the FDA, i.e. CEA, Her-2/neu, bladder tumor antigen, thyroglobulin, alpha-fetoprotein, PSA, CA125, CA19.9, CA15.3. This evidence concerns the gene KLK3 and neoplasm.